NYC vs OMH

The company exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. While the stock trades at a deep discount to book value (P/B 0.30), this is likely a value trap given the catastrophic revenue decline of -56.50% YoY and deeply negative operating margins. High leverage (Debt/Equity 3.86) combined with a bearish technical trend (0/100) suggests significant downside risk and potential insolvency concerns.

OMH presents a high-risk profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a complete lack of positive technical momentum. While the company demonstrates strong top-line revenue growth (48.9% YoY) and maintains a very clean balance sheet with minimal debt, these are overshadowed by severe operational losses and a negative ROE of -59.67%. The stock is in a catastrophic long-term downtrend, losing over 51% of its value in the last year, suggesting the market is pricing in significant sustainability concerns.